Global Alpha N-Acetylglucosaminidase Market Professional Survey Report 2019
SKU ID : QYR-14867745 | Publishing Date : 06-Nov-2019 | No. of pages : 109
The global Alpha N-Acetylglucosaminidase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Alpha N-Acetylglucosaminidase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alpha N-Acetylglucosaminidase market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Alpha N-Acetylglucosaminidase in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Alpha N-Acetylglucosaminidase manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abeona Therapeutics, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Dorphan S.A.
Laboratorios Del Dr. Esteve S.A.
UniQure N.V.
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Lesinidase Alfa
EGT-201
BMN-250
ABO-101
Others
Segment by Application
In-Patient
Out-Patient
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region